Literature DB >> 3447930

Electrophysiological analysis of the action of nifedipine and nicardipine on myocardial fibers.

P Charnet1, H Ouadid, S Richard, J Nargeot.   

Abstract

The effects of nifedipine and nicardipine, 2 dihydropyridines (DHP) used in the treatment of cardiovascular disorders, were compared in frog atrial fibers. Rapid photolysis of nifedipine with a single UV flash (1-ms duration) reversed the block, allowing comparison of effects of both drugs on the same preparation, and manipulation of the calcium channel on a millisecond timescale. The results show that inhibition of the action potential (AP) and slow inward current (Isi) is more pronounced with nifedipine than with nicardipine. Concentration-effect relationships confirm that nicardipine (IC50 = 1 microM) is less potent than nifedipine (IC50 = 0.2 microM) in blocking cardiac calcium channels. Both DHP block calcium channels in the closed state at the resting potential, inducing a large tonic block (in the absence of stimulation). An additional phasic block can be observed with nifedipine and nicardipine. A slight voltage dependence to the block is observed for both DHP, their effects being enhanced depolarization holding potentials. Rapid unblocking of calcium channels by a single light flash, presented during the decay phase of Isi, reveals a higher affinity of DHP for inactivated channels. This effect is most pronounced when inactivation is slowed by using Ba++, Sr++, or Na+ ions as the current carriers. Open channel block is also suggested. The mechanism of DHP action on calcium channels can be described according to the "modulated receptor hypothesis". These DHP exhibit an additional nonspecific effect on potassium channels. It is concluded that nicardipine is a less potent Ca++ antagonist than nifedipine in atrial fibers and that the reduction of delayed potassium current, which occurs in a similar range of concentrations to the blockade of Isi, could also be involved in its therapeutic effects.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3447930     DOI: 10.1111/j.1472-8206.1987.tb00575.x

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN: 0767-3981            Impact factor:   2.748


  5 in total

1.  Field and action potential recordings in heart slices: correlation with established in vitro and in vivo models.

Authors:  Herbert M Himmel; Alexandra Bussek; Michael Hoffmann; Rolf Beckmann; Horst Lohmann; Matthias Schmidt; Erich Wettwer
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  Effects of inhibition of calcium and potassium currents in guinea-pig cardiac contraction: comparison of beta-caryophyllene oxide, eugenol, and nifedipine.

Authors:  O Sensch; W Vierling; W Brandt; M Reiter
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

3.  Dihydropyridine block of voltage-dependent K+ currents in rat dorsal root ganglion neurons.

Authors:  X-L Zhang; M S Gold
Journal:  Neuroscience       Date:  2009-03-13       Impact factor: 3.590

4.  Kinase inhibitor screening using artificial neural networks and engineered cardiac biowires.

Authors:  Genevieve Conant; Samad Ahadian; Yimu Zhao; Milica Radisic
Journal:  Sci Rep       Date:  2017-09-18       Impact factor: 4.379

5.  Mapacalcine protects mouse neurons against hypoxia by blocking cell calcium overload.

Authors:  Hamid Moha Ou Maati; Catherine Widmann; Djamila Sedjelmaci; Djamila Sedjelmaci Bernard Gallois; Bernard Gallois; Djamila Sedjelmaci Bernard Gallois; Catherine Heurteaux; Marc Borsotto; Michel Hugues
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.